Search / Trial NCT06221397

Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma

Launched by AI LABS GROUP S.L · Jan 23, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

Melanoma Primary Care Dermatology Diagnosis Artificial Intelligence Severity

ClinConnect Summary

This clinical trial is studying a new computer program designed to help detect skin cancer, specifically a type called melanoma. The program uses artificial intelligence (AI) to analyze images of suspicious skin lesions taken with a special camera. Researchers want to find out if this AI tool can accurately identify melanoma and how well it performs compared to doctors' assessments. The study will involve patients who have skin lesions that might be cancerous and will take place at two hospitals.

To participate, you need to be over 18 years old and have a skin lesion that doctors suspect could be malignant (cancerous). If you join the study, you won't receive any specific treatment for your skin lesions during the trial; instead, you'll continue any regular treatments prescribed by your doctor. All you will need to do is have your skin lesions photographed during a visit. This study is currently recruiting participants, and it's a great opportunity to help advance the use of technology in early skin cancer detection.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with skin lesions with suspected malignancy
  • Age over 18 years old
  • Patients who consent to participate in the study by signing the Informed Consent form
  • Exclusion Criteria:
  • Patients under 18 years of age

Trial Officials

Jesús Gardeazabal, PhD

Principal Investigator

Hospital Universitario Cruces

Rosa María Ize, PhD

Principal Investigator

Hospital Universitario Basurto

About Ai Labs Group S.L

ai labs group s.l. is an innovative clinical trial sponsor dedicated to advancing healthcare through the integration of artificial intelligence and data-driven methodologies. With a focus on enhancing the efficiency and reliability of clinical research, the organization collaborates with a diverse range of stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. By leveraging cutting-edge technology and a multidisciplinary approach, ai labs group s.l. aims to streamline clinical trial processes, improve patient outcomes, and accelerate the development of new therapies. Their commitment to ethical research practices and regulatory compliance ensures that all clinical trials meet the highest standards of safety and efficacy.

Locations

Barakaldo, Biscay, Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0